StockGlow

Clinuvel Pharmaceuticals Limited (CUVL)

Develops skin-protective medicines using melanocortin technology for rare genetic disorders and UV damage

$7.01+0.00%Healthcare
Compare CUVL with
StockGlow Score
41
Neutral
BearishBullish
1 year ago-11.3%

The outlook

CUVL is trading near the lower third of its 52-week range, sitting flat today. Analyst coverage appears limited, and the stock shows mixed positioning relative to its moving averages. The trailing P/E of 15.6 sits at a moderate valuation level.

What’s behind the score

Price trendMixed vs its moving averages
52-week range34% of the way from its 52-week low to high
Market cap
$353.5M
52-wk high
$9.00
52-wk low
$5.98
50-day avg
$6.92
200-day avg
$7.36
Trailing P/E
15.6

Similar stocks

CLVLFClinuvel Pharmaceuticals Limited$6.10+0.00%CUV.AXClinuvel Pharmaceuticals Limited$9.59-2.24%SPHRYStarpharma Holdings Limited$5.30+14.72%CSLLYCSL Limited$21.04+3.44%CMSQYComputershare Limited$28.44+1.79%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy